Related Experiment Videos

Evaluating methods for improving ultrafiltration in pediatric hemodialysis

Daljit K Hothi1, Elizabeth Harvey, Cristina M Goia

  • 1Division of Nephrology, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada.

Pediatric Nephrology (Berlin, Germany)
|January 25, 2008
PubMed

Insights

Mannitol and sodium ramping improved ultrafiltration (UF) in pediatric hemodialysis patients, reducing intradialytic symptoms. However, achieving target dry weight remains a challenge, with UF profiles showing no clear benefit.

Area of Science:

  • Nephrology
  • Pediatric Nephrology
  • Critical Care Medicine

Background:

  • Adequate ultrafiltration (UF) is crucial for patient health but often limited by intradialytic symptoms and hypotension.
  • Pediatric hemodialysis requires optimized strategies to achieve sufficient fluid removal while maintaining patient stability.

Purpose of the Study:

  • To evaluate the efficacy of sodium ramping, UF profiles, and mannitol in enhancing UF and reducing complications in children undergoing chronic hemodialysis.
  • To determine if these interventions could help achieve target dry weight more effectively.

Main Methods:

  • A prospective analysis of 506 hemodialysis treatments from ten pediatric patients.
  • Implementation of a standardized prescription including sodium ramping (148-138 mmol/l) and various UF profiles.
  • Assessment of UF volumes, intradialytic symptoms, hypotension, and achievement of dry weight.

Main Results:

  • Mannitol significantly reduced the risk of intradialytic symptoms by 64% (p < 0.05), achieving a mean UF of 6.2%.
  • Step sodium ramping (148-138 mmol/l) decreased the likelihood of intradialytic symptoms and hypotension (p < 0.05) compared to linear profiles.
  • While UF volumes exceeding 5% of dry weight were achieved (mean 5.4%, up to 9.7%), target dry weight was not reached in 66% of treatments.
  • UF profiles, particularly stepwise reduction, were associated with an increased risk of intradialytic symptoms, with no clear overall benefit.

Conclusions:

  • Mannitol and specific sodium ramping protocols show promise in improving UF and patient tolerance during pediatric hemodialysis.
  • Current strategies, including UF profiles, may not be sufficient to consistently achieve target dry weight in all pediatric patients.
  • Further research is needed to optimize fluid management and dry weight achievement in this population.

Related Concept Videos

Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...